Hepatocellular Cancer
Researchers from Duke University publish new studies and findings in the area of hepatocellular cancer
Published in Cancer Weekly, March 25th, 2008
"In the current system of allocation, patients awaiting orthotopic liver transplantation (OLT) remain at risk of developing de novo hepatocellular carcinoma (HCC) and removal from the waiting list. Using the United Network for Organ Sharing database, we calculated the rate and identified predictors of de novo HCC in patients listed for OLT between February 2002 and December 2004," scientists writing in the journal Liver Transplantation report.
"Among 8566 patients, 1167 (13.6%) developed de novo HCC. Predictors of increased odds of de novo HCC were older age, male gender, Asian race, other race, hepatitis C, and hepatitis B. A sensitivity analysis of 2067...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2008-03-25)
More Articles from Cancer Weekly
- Phototherapy
Combined stenting and photodynamic therapy improves survival in late stage liver cancer patients - Ataxia Telangiectasia
Findings from M.L. Cortes and co-researchers advance knowledge in ataxia telangiectasia - Biologics
Raven biotechnologies Advances RAV18 Through Agreement With CMC ICOS Biologics - Cancer
Power3 Medical Products Inc. Publishes Discovery of Protein Biomarkers for Esophageal Malignancies in the International Journal of Cancer - Cancer Gene Therapy
New cancer gene therapy research has been reported by scientists at Oita University, Medical Department - Cancer Gene Therapy
Reports outline cancer gene therapy study results from Dankook University - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
